| The population pharmacokinetics of the novel recombinant human follicle-stimulating hormone FE 999049 have been characterised in healthy females after single ascending dosing. |
| Follicle-stimulating hormone measurements below the quantification limit were accounted for by the model. |
| Body weight influences exposure to FE 999049 and may be an important factor for dosage considerations. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.